PRDM1 and neoplasm: Xia et al. revealed that homozygous deletions of PRDM1 correlated with decreased plasma cell differentiation and upregulation of genes involved in tumor cell proliferation in activated B-cell-like diffuse large B-cell lymphoma (ABC-DLBCL) patients [48].